相关实验视频
Updated: Jul 1, 2025

05:47
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
7.2K
肠道微生物CAZymes是抑郁症的标志物
Peijun Xie1,2, Xingyu Zhou1,2, Yifan Li1,2
1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Translational psychiatry
|March 5, 2024
概括
大型抑郁症 (MDD) 涉及肠道微生物组的变化. 特定的碳水化合物活性酶 (CAZymes),如糖化水解酶 (GHs) 和多糖化酶 (PLs),在MDD患者中不同,有助于诊断和预测治疗反应.
科学领域:
- 微生物组研究的研究.
- 转基因组学是指转基因组学.
- 心理健康 心理健康
背景情况:
- 大型抑郁症 (MDD) 与肠道微生物组的改变有关.
- 了解MDD中碳水化合物活性酶 (CAZymes) 的变化至关重要.
研究的目的:
- 为了研究患有MDD的患者肠道CAZymes的变化.
- 为了确定潜在的CAZyme-based生物标志物用于MDD诊断和治疗预测.
主要方法:
- 对118名MDD患者和118名健康对照 (HC) 的元基因组数据分析.
- 在MDD和HC组之间比较CAZyme资料和多样性指数.
- 基于CAZyme的歧视标记面板的开发和验证.
主要成果:
- 在MDD和HC组之间,CAZyme总体特征和α多样性的显著差异.
- 患有MDD的患者表现出糖酸水解酶 (GHs) 和多糖酸酸酶 (PLs) 的丰富.
- 一个9-CAZyme小组以0.824的AUC将MDD与HC区分开来,并将0.736.6的AUC分类为盲目样本.
- 4个CAZymes的基线水平预测了抗抑郁药的有效性.
结论:
- MDD与肠道CAZyme概况的显著干扰有关.
- CAZymes具有作为MDD的诊断生物标志物的潜力.
- CAZyme水平可以预测抗抑郁药治疗结果.
相关概念视频
Depression: Overview
243
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
243
G-protein Coupled Receptors
118.8K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.8K
Antidepressant Drugs: MAOIs and Other Agents
229
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
229

